Regenerative Medicine
for Foot & Ankle Conditions
Harnessing the body’s own healing power — and the most advanced biologics available — to repair, regenerate, and restore. From PRP and stem cells to allograft cartilage and advanced wound care, we offer the full spectrum of regenerative options.
Modern foot and ankle medicine has moved far beyond the binary of “take these pills or have surgery.” Regenerative medicine occupies the space in between — using biological therapies, advanced biomaterials, and energy-based technologies to repair damaged tissue, restore joint function, heal chronic wounds, and support nerve recovery. For patients who have exhausted conventional treatments or who want to avoid surgery, these options can be genuinely transformative.
What Is Regenerative Medicine for the Foot and Ankle?
Regenerative medicine is a broad category of medical treatments designed to stimulate, support, or replace the body’s natural tissue repair processes. Rather than managing symptoms with medication or replacing a structure through surgery, regenerative therapies aim to restore the biological environment needed for tissue to heal itself — or to provide the biological building blocks the body can no longer produce in sufficient quantity on its own.
The foot and ankle are particularly well-suited to regenerative approaches. The structures most commonly damaged in this region — tendons, fascia, cartilage, peripheral nerves, and skin — all have limited natural blood supply and therefore limited inherent healing capacity. This is precisely why conditions like plantar fasciitis, Achilles tendinopathy, ankle arthritis, and diabetic foot ulcers so often become chronic: the tissue simply cannot repair itself adequately without biological assistance.
At The Foot and Ankle Medical Group, we offer the full spectrum of FDA-cleared and evidence-supported regenerative therapies for foot and ankle conditions. The right treatment — or combination of treatments — is selected based on your diagnosis, the chronicity of your condition, your overall health status, and your goals for recovery.
Who Is a Candidate for Regenerative Medicine?
Platelet-Rich Plasma (PRP) Therapy
How PRP Works
Platelet-Rich Plasma therapy begins with a simple blood draw from your arm — the same process as any routine lab work. The blood is then processed in a centrifuge that separates and concentrates the platelets, which are the cells responsible for initiating and orchestrating the body’s healing response. The resulting PRP contains a concentration of platelets 5 to 10 times higher than normal whole blood, packed with growth factors including PDGF, VEGF, TGF-β, and IGF-1.
This concentrated healing solution is injected directly into the damaged tissue under ultrasound guidance, delivering a powerful burst of biological signals that recruit stem cells, stimulate collagen production, promote new blood vessel formation, and accelerate the repair of degenerated tissue. Because PRP is derived from your own blood, there is no risk of allergic reaction or disease transmission.
Foot and Ankle Conditions Treated with PRP
PRP vs. Cortisone: Understanding the Difference
Corticosteroid (cortisone) injections reduce inflammation rapidly and provide short-term pain relief — but they do not repair the underlying damaged tissue. Repeated cortisone injections can actually weaken tendon and fascial tissue over time, increasing the risk of rupture. PRP, by contrast, stimulates the body to repair the damaged tissue itself. The effects of PRP take longer to appear — typically 4 to 8 weeks — but the results are more durable because the underlying pathology is being addressed rather than suppressed.
| Feature | Cortisone Injection | PRP Injection |
|---|---|---|
| Mechanism | Reduces inflammation | Stimulates tissue repair |
| Onset of relief | Days to 1 week | 4–8 weeks |
| Duration of effect | Weeks to months | Months to years |
| Tissue effect | Can weaken with repeated use | Strengthens and repairs |
| Source | Synthetic steroid | Your own blood (autologous) |
| Best for | Acute flares, rapid relief | Chronic, degenerative conditions |
PRP injections are performed in-office under ultrasound guidance for precision. The procedure takes approximately 30 to 45 minutes including the blood draw and processing time. Mild soreness at the injection site is common for 3 to 5 days following treatment — this is a normal part of the healing response. Most patients require one to three injections, spaced 4 to 6 weeks apart, for optimal results. Activity modifications will be provided based on the treated structure.
Stem Cell Therapy for Foot & Ankle Conditions
The Science Behind Stem Cell Therapy
Stem cells are the body’s master repair cells — undifferentiated cells with the remarkable ability to transform into the specific type of tissue needed at the site of injury. Mesenchymal stem cells (MSCs), the type most relevant to foot and ankle regenerative medicine, can differentiate into cartilage, tendon, ligament, bone, and muscle cells. They also release powerful anti-inflammatory and regenerative signaling molecules (cytokines and growth factors) that orchestrate the healing environment around them.
In regenerative medicine, stem cells are harvested from the patient’s own bone marrow (bone marrow aspirate concentrate — BMAC) or adipose (fat) tissue, concentrated, and injected precisely into the target structure under ultrasound or fluoroscopic guidance. Alternatively, allogeneic (donor-derived) amniotic or umbilical cord-derived stem cell products are available for patients who prefer to avoid a harvesting procedure.
Foot and Ankle Conditions Treated with Stem Cell Therapy
Stem Cell Therapy for Arthritis and Hallux Rigidus
Arthritis of the ankle joint and hallux rigidus (arthritis of the first metatarsophalangeal joint at the base of the big toe) are among the most debilitating foot and ankle conditions — and historically, patients faced a stark choice between conservative palliative care and surgery. Stem cell therapy offers a meaningful third option.
Injected mesenchymal stem cells in an arthritic joint have been shown to reduce inflammatory cytokines, promote the synthesis of new cartilage matrix, and slow the progression of cartilage degeneration. In patients with early-to-moderate arthritis or hallux rigidus, stem cell injections can significantly reduce pain and improve joint mobility — delaying or potentially avoiding the need for surgical joint fusion or replacement. Results are most durable in patients with mild-to-moderate disease who are treated before end-stage joint destruction occurs.
Stem cell therapy is particularly promising for hallux rigidus — a condition where surgical options (cheilectomy or fusion) carry significant recovery burdens. Patients with Grade I to III hallux rigidus who receive stem cell injections often experience meaningful pain reduction and improved range of motion, with results lasting 12 to 24 months or longer. This is especially valuable for active patients who depend on full toe mobility for sports, dance, or occupational demands.
Autologous stem cells (from your own bone marrow or fat) offer the advantage of being immunologically identical to your body’s cells — zero rejection risk. The trade-off is a minor harvesting procedure. Allogeneic products derived from donated amniotic or umbilical cord tissue are processed and screened rigorously and do not require a harvesting step. Your physician will discuss which source is most appropriate for your specific diagnosis and clinical situation.
Vitamin B Complex for Peripheral Neuropathy
The Role of B Vitamins in Nerve Health and Repair
The B vitamins are essential cofactors in nearly every aspect of peripheral nerve function and repair. Deficiencies in B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin) are among the most common and reversible causes of peripheral neuropathy — yet they are frequently overlooked in the evaluation of patients presenting with foot numbness, tingling, burning, and pain. At The Foot and Ankle Medical Group, assessment of B vitamin status is a routine part of our neuropathy evaluation protocol.
Vitamin B12, in particular, is essential for the synthesis and maintenance of myelin — the protective sheath surrounding peripheral nerve fibers. Without adequate B12, the myelin sheath degenerates, slowing or blocking nerve signal transmission and producing the classic symptoms of peripheral neuropathy. B1 is critical for nerve energy metabolism, and B6 is required for neurotransmitter synthesis. Together, the B complex forms the biochemical foundation of a healthy peripheral nervous system.
Conditions Causing Neuropathy That Respond to B Vitamin Therapy
Diabetes-Related Peripheral Neuropathy
Diabetic peripheral neuropathy is the most common form of neuropathy in the United States, affecting approximately 50 percent of people with long-standing diabetes. Chronic hyperglycemia damages nerve blood vessels (vasa nervorum), impairing nerve nutrition and repair. Additionally, metformin — one of the most commonly prescribed diabetes medications — is known to deplete vitamin B12 levels, potentially worsening neuropathy in patients who are already at risk. Supplementation with high-dose B12 and the full B complex can partially reverse neuropathic symptoms and support the nerve repair process in diabetic patients, particularly when initiated before irreversible axonal loss has occurred.
Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Many chemotherapy agents — including taxanes (paclitaxel, docetaxel), platinum compounds (cisplatin, oxaliplatin), and vinca alkaloids (vincristine) — are neurotoxic. They damage peripheral sensory nerves, causing a dose-dependent neuropathy that manifests as numbness, tingling, burning, and pain in the feet and hands. CIPN can persist long after chemotherapy is completed. B complex supplementation, particularly B6 and B12, plays a supportive role in nerve maintenance during and after chemotherapy, and emerging evidence supports its use as part of a comprehensive CIPN management strategy. Coordination with the patient’s oncologist is essential before initiating supplementation during active treatment.
Charcot-Marie-Tooth Disease (CMT)
Charcot-Marie-Tooth disease is the most common inherited peripheral neuropathy, caused by mutations in genes responsible for myelin production or axonal function. Patients develop progressive weakness and sensory loss in the feet and lower legs, often accompanied by foot deformities including high arches (pes cavus), hammertoes, and foot drop. While B vitamin supplementation cannot correct the underlying genetic defect, optimizing B12, B6, and B1 levels supports the best possible nerve function within the constraints of the disease and may reduce the pace of symptom progression. Podopediatric and podiatric management of CMT-related foot deformities — through orthotics, bracing, and when necessary surgery — is an essential component of comprehensive care.
Vitamin Deficiency-Related Neuropathy
Neuropathy from nutritional deficiency is entirely preventable and, when caught early, largely reversible. Risk groups include strict vegans and vegetarians (B12 is found almost exclusively in animal products), patients who have undergone bariatric surgery (impaired absorption), elderly individuals (reduced gastric acid production impairs B12 absorption), and patients on long-term proton pump inhibitors or metformin. Correcting the deficiency with targeted supplementation — or B12 intramuscular injection in cases of severe malabsorption — can produce meaningful reversal of neuropathic symptoms over 3 to 6 months of consistent treatment.
At The Foot and Ankle Medical Group, every patient presenting with peripheral neuropathy symptoms undergoes a thorough clinical evaluation that includes neurological testing of the feet, vibration and monofilament sensory assessment, review of medications known to affect B vitamin levels, and laboratory evaluation of B12, folate, and metabolic markers when indicated. This comprehensive approach ensures we identify treatable causes of neuropathy and address them alongside any structural foot and ankle management.
Extracorporeal Shock Wave Therapy (ESWT)
How Extracorporeal Shock Wave Therapy Works
Extracorporeal Shock Wave Therapy uses a specialized device to generate and deliver focused acoustic pressure waves — shock waves — to a targeted area of damaged tissue through the skin, without any incision. The term “extracorporeal” simply means “outside the body,” referring to the fact that the energy is generated externally and transmitted into the tissue.
At the cellular level, shock waves produce several powerful biological effects: they stimulate the production of growth factors (including VEGF and TGF-β), promote the formation of new blood vessels (neovascularization) in poorly vascularized tissue, break down calcifications within tendons and fascia, modulate pain-transmitting nerve fibers, and activate the body’s natural tissue repair cascade. The result is a genuine regenerative response in tissue that had previously failed to heal on its own — not merely symptomatic relief.
FDA Clearance and Clinical Evidence
ESWT holds FDA clearance for the treatment of chronic plantar fasciitis and is supported by a robust body of clinical evidence. Multiple randomized controlled trials demonstrate superiority over placebo for chronic plantar fasciitis, Achilles tendinopathy, and calcific tendinitis. It is particularly valuable as a bridge between failed conservative care and surgery — offering a meaningful non-invasive option before a patient commits to an operative procedure.
Foot and Ankle Conditions Treated with ESWT
What to Expect During ESWT Treatment
-
1Pre-Treatment Evaluation Your podiatrist will confirm your diagnosis and identify the precise target zone using clinical examination and ultrasound imaging. ESWT requires accurate targeting to deliver the energy to the correct tissue — diffuse or inaccurate application reduces efficacy.
-
2The Treatment Session Ultrasound gel is applied to the skin over the target area and the ESWT applicator is positioned. A series of shock waves are delivered over approximately 15 to 20 minutes. Patients typically feel a strong pressure or tapping sensation — the intensity is adjustable and is titrated to your tolerance. No incisions, no anesthesia, no downtime.
-
3Treatment Course Most patients receive three to five weekly treatment sessions. The regenerative response builds progressively between sessions — patients often notice continued improvement for 8 to 12 weeks after completing the treatment course as the biological repair process matures.
-
4Post-Treatment Protocol A brief period of reduced high-impact activity following each session supports the healing response. Stretching protocols and custom orthotics — when biomechanical factors are present — are continued alongside ESWT to address the root cause of the condition and reduce recurrence risk.
For patients with chronic plantar fasciitis who have failed 6 months of conservative care, ESWT is the recommended next step before surgery. Clinical data shows that approximately 70 to 80 percent of patients who complete an ESWT course avoid surgical intervention entirely. ESWT carries no surgical risks, requires no recovery time, and can be repeated if needed. Surgery is reserved for the small percentage of patients who do not achieve adequate relief with ESWT and other non-surgical measures.
Advanced Skin Substitutes for Diabetic Wound Healing
The Challenge of Diabetic Foot Wounds
Diabetic foot ulcers represent one of the most serious and costly complications of diabetes. Approximately 15 percent of all people with diabetes will develop a foot ulcer during their lifetime, and diabetic foot ulcers account for more than 80 percent of all lower extremity amputations in the United States. The underlying biology of diabetic wound healing is profoundly impaired — elevated blood glucose damages the blood vessels that supply healing nutrients, neuropathy eliminates the protective pain signals that would normally prompt care, and the immune environment within the wound is chronically dysregulated.
Standard wound care — debridement, dressings, offloading — is the necessary foundation of diabetic wound management, but it is often insufficient for wounds that have failed to progress toward healing over 4 weeks or more. Advanced skin substitutes are where modern wound biologics step in to change the trajectory of these difficult wounds.
What Are Advanced Skin Substitutes?
Advanced skin substitutes — also called cellular and/or tissue-based products (CTPs) — are biologically derived wound coverage materials that go far beyond a standard dressing. They provide the cellular scaffolding, growth factors, extracellular matrix proteins, and bioactive molecules that a diabetic wound environment can no longer generate on its own. When applied to a properly prepared wound bed, they essentially restart the healing cascade that diabetes has stalled.
These products fall into several categories, each with distinct mechanisms and indications:
| Product Type | Source | Key Mechanism | Best Indicated For |
|---|---|---|---|
| Acellular dermal matrices | Human or bovine dermis | Scaffold for cellular ingrowth | Full-thickness wounds, tendon exposure |
| Amniotic membrane allografts | Human placental tissue | Growth factors, anti-inflammatory cytokines | Stalled chronic diabetic ulcers |
| Bilayered living cell constructs | Living keratinocytes and fibroblasts | Active cytokine delivery, matrix production | Neuropathic ulcers not responding to standard care |
| Umbilical cord-derived allografts | Human umbilical cord tissue | MSCs, growth factors, Wharton’s jelly | Chronic, recalcitrant wounds |
| Fish skin grafts (omega-3 matrix) | Atlantic cod or tilapia | Intact collagen scaffold, anti-inflammatory | Superficial to partial-thickness wounds |
The Treatment Protocol for Diabetic Wound Care
Advanced skin substitutes are not applied to an unprepared wound. Successful outcomes depend on a rigorous preparation protocol that must precede and accompany biologic application:
A diabetic foot ulcer that has not decreased in size by at least 50 percent after 4 weeks of standard wound care should be evaluated for advanced skin substitute therapy — not managed with the same approach for another 4 weeks. Time is tissue. Every week a diabetic wound remains open increases the risk of deep infection, osteomyelitis (bone infection), and ultimately amputation. Early escalation to advanced biologics significantly improves limb salvage outcomes.
Insurance Coverage for Advanced Skin Substitutes
Many advanced skin substitute products are covered by Medicare and commercial insurance when applied to qualifying diabetic or neuropathic wounds that meet clinical criteria. Coverage typically requires documentation of wound chronicity (greater than 30 days), failure of standard wound care, appropriate wound preparation, and a supporting diagnosis. Our wound care team manages the documentation and prior authorization process to minimize barriers to access for qualifying patients.
Human Allograft Cartilage Replacement for Joint Restoration
Restoring the Joint Without Total Replacement
Cartilage is one of the most challenging tissues in the body to repair. It has no direct blood supply and essentially no ability to regenerate on its own once damaged. For decades, the options for significant cartilage loss in the foot and ankle — from arthritis, hallux rigidus, osteochondral lesions, or traumatic injury — were limited to palliative management or surgery. Human allograft cartilage products represent a significant advance in our ability to biologically restore joint surfaces without the risks and recovery burden of major joint surgery.
Human allograft cartilage is derived from rigorously screened and processed donor tissue. These products contain viable chondrocytes (cartilage cells), an intact extracellular matrix of collagen and proteoglycans, and in some formulations, chondrogenic growth factors that support integration and new cartilage production. When implanted into a prepared joint surface, allograft cartilage can fill defects, reduce pain, and restore a more biomechanically functional joint surface.
Hallux Rigidus: Restoring the Big Toe Joint
Hallux rigidus is progressive arthritis of the first metatarsophalangeal joint — the joint at the base of the big toe. It is the most common arthritic condition of the foot, affecting an estimated 1 in 40 adults over age 50, and it significantly impacts the ability to walk, run, climb stairs, and wear normal footwear. The characteristic features are progressive stiffness of the big toe, a dorsal (top-of-foot) bone spur, and pain with extension of the toe — precisely the motion required for normal walking push-off.
Traditional surgical management of advanced hallux rigidus has been either cheilectomy (removal of the bone spur) for mild cases or arthrodesis (joint fusion) for severe cases. Joint fusion is definitive but permanently eliminates motion — a significant functional trade-off, particularly for active patients. Human allograft cartilage procedures, performed arthroscopically or through a minimal open approach, offer the possibility of restoring the joint surface and preserving motion in appropriately selected patients with Grade II to III hallux rigidus, potentially avoiding or delaying the need for fusion.
| Hallux Rigidus Grade | Joint Appearance | Symptoms | Allograft Candidacy |
|---|---|---|---|
| Grade I (Mild) | Minimal joint space loss, small spur | Mild stiffness, pain with extremes of motion | Conservative care preferred; PRP or stem cell injection |
| Grade II (Moderate) | Moderate joint space loss, moderate spur | Moderate stiffness, consistent pain with activity | ✓ Good candidate for allograft cartilage procedure |
| Grade III (Severe) | Significant joint space loss, large spur | Significant stiffness, pain at rest | ✓ May benefit — evaluate individually |
| Grade IV (End-Stage) | Complete joint space loss, bone-on-bone | Severe pain, minimal motion, constant discomfort | Fusion typically recommended; biologics as adjunct |
Ankle Arthritis: Biological Joint Preservation
Ankle osteoarthritis, while less common than knee or hip arthritis, is profoundly disabling. It is most often post-traumatic in origin — developing years after an ankle fracture or repetitive ankle sprains. The ankle joint bears three times body weight with each step, making even modest cartilage loss clinically significant. Total ankle replacement and ankle fusion are the established surgical end-points — but for patients with partial cartilage loss or focal osteochondral defects, allograft cartilage procedures offer a biologically restorative option that preserves joint motion and delays or avoids major reconstructive surgery.
Osteochondral allograft transplantation (OAT) uses a precisely sized plug of donor cartilage and underlying bone to fill a focal cartilage defect in the talus — the most common site of osteochondral injury in the ankle. The graft integrates with the native bone over several months, providing a durable biological repair of the joint surface. Combined with PRP or stem cell augmentation at the time of surgery, the regenerative environment for graft integration is further optimized.
The most powerful outcomes in regenerative foot and ankle medicine frequently come from combining complementary therapies. For example: a patient with moderate hallux rigidus might receive a stem cell injection for the arthritic joint combined with ESWT for any associated capsular inflammation and custom orthotics to offload the joint during healing. A patient with a chronic diabetic ulcer overlying tendon might receive an advanced skin substitute for wound closure while concurrently undergoing B12 optimization for their underlying neuropathy. Our physicians design individualized regenerative protocols rather than applying single-modality approaches.
Am I a Candidate for Regenerative Medicine?
The most important step in regenerative medicine is careful patient selection. Not every condition, and not every patient, is the right fit for every therapy — and using the wrong treatment at the wrong time can delay more appropriate care. At The Foot and Ankle Medical Group, candidacy for regenerative therapy is determined through a comprehensive evaluation that includes your clinical history, physical examination, imaging review, and discussion of your treatment goals.
General Candidacy Considerations
| Therapy | Ideal Candidate | Relative Contraindications |
|---|---|---|
| PRP Injection | Chronic tendon/fascia injury, failed conservative care 3–6 months | Active infection, platelet disorders, blood thinners |
| Stem Cell Therapy | Mild–moderate arthritis, cartilage defects, chronic tendon tears | Active cancer, severe end-stage joint disease, active infection |
| ESWT | Chronic plantar fasciitis or Achilles tendinopathy, failed 6 months conservative | Pregnancy, pacemaker, active growth plates (children), blood thinners |
| Vitamin B Complex | Any neuropathy — diabetic, chemotherapy-induced, deficiency, CMT | Very few — discuss with physician if on specific medications |
| Advanced Skin Substitutes | Diabetic/neuropathic ulcer not healing after 4 weeks standard care | Active osteomyelitis, inadequate vascular supply, active infection |
| Allograft Cartilage | Grade II–III hallux rigidus, focal osteochondral defect of talus | End-stage arthritis, active infection, significant bone loss |
Regenerative medicine is a rapidly evolving field, and the evidence base continues to expand. At The Foot and Ankle Medical Group, we stay current with the peer-reviewed literature and clinical guidelines to ensure our patients have access to therapies with genuine evidence of efficacy — not experimental treatments offered without clinical basis. Every regenerative recommendation we make is grounded in the best available evidence, individualized to your diagnosis, and presented transparently with realistic expectations about outcomes and timelines.
Frequently Asked Questions About Regenerative Medicine
Traditional treatments for foot and ankle conditions typically focus on symptom management — reducing pain and inflammation with medication, or removing or replacing damaged structures through surgery. Regenerative medicine takes a fundamentally different approach: it uses biological agents, energy-based therapies, and advanced biomaterials to stimulate the body’s own repair processes, promote tissue healing, and restore function at the cellular level. The goal is to repair the problem rather than mask it or cut it out.
PRP therapy is currently considered investigational by most commercial insurance carriers and Medicare for musculoskeletal applications and is typically not covered. The cost of PRP is an out-of-pocket expense for most patients. However, the investment should be weighed against the cost of ongoing conservative treatments, potential surgery, and associated recovery time. Our team will provide transparent cost information during your consultation and can discuss financing options.
The number of injections varies by condition and individual response. For plantar fasciitis and tendinopathy, most patients receive one to three PRP injections spaced 4 to 6 weeks apart. For joint conditions such as hallux rigidus or ankle arthritis, a single stem cell injection is often the starting point, with repeat injections considered based on clinical response at 3 to 6 months. Your physician will establish a treatment plan with defined reassessment points rather than open-ended injection schedules.
ESWT produces a strong pressure or tapping sensation at the treatment site during the session. Most patients describe it as moderately uncomfortable rather than painful, and the intensity is adjustable — your physician will titrate the energy level to a level you can tolerate. The discomfort lasts only during the treatment session (typically 15 to 20 minutes) and resolves immediately afterward. Some patients experience mild soreness for 24 to 48 hours after treatment, which is a normal part of the biological response. No anesthesia is required.
In many cases, regenerative medicine can delay, reduce the scope of, or entirely avoid the need for surgery. This is particularly true for conditions like chronic plantar fasciitis (where ESWT or PRP often achieves lasting relief), early-to-moderate hallux rigidus (where stem cell therapy or allograft procedures can restore joint function), and chronic diabetic wounds (where advanced skin substitutes can achieve closure that previously would have required surgical debridement and grafting). However, regenerative medicine is not appropriate for every case — end-stage joint disease, complete tendon ruptures, and certain structural deformities still require surgical correction.
Regenerative therapies work by stimulating biological repair processes, which take time. PRP patients typically begin noticing improvement at 4 to 8 weeks, with maximum benefit at 3 to 6 months. Stem cell therapy follows a similar timeline. ESWT patients often see progressive improvement over 8 to 12 weeks following their treatment course. Advanced skin substitutes may begin showing wound progression within 2 to 4 weeks of application. Unlike cortisone — which reduces pain within days by suppressing inflammation — regenerative therapies are healing rather than masking, and patience is an important part of the process.
Vitamin B complex supplementation is generally very safe when taken at appropriate doses. However, high-dose B6 (pyridoxine) supplementation — typically above 100mg per day sustained over months — can paradoxically cause a peripheral neuropathy of its own, known as pyridoxine toxicity neuropathy. For this reason, it is important that neuropathy patients discuss B vitamin supplementation with their physician rather than self-medicating with high-dose over-the-counter products. Our physicians will recommend appropriate dosing based on your deficiency levels, underlying condition, and concurrent medications.
The Foot and Ankle Medical Group offers the full spectrum of regenerative foot and ankle medicine — PRP therapy, stem cell injections, ESWT, vitamin B complex neuropathy protocols, advanced skin substitutes, and human allograft cartilage procedures — at our locations in Mountain View, Los Gatos, San Jose, and Monterey, California. All services are provided by board-certified foot and ankle surgeons with specialized training in regenerative techniques. Contact us to schedule a consultation and find out which regenerative options are right for your specific condition.
Medical Disclaimer: The information in this article is intended for general educational purposes and does not constitute individualized medical advice. Regenerative medicine treatments for the foot and ankle should be evaluated and prescribed by a licensed physician following a thorough clinical examination. Individual results vary. If you are experiencing foot or ankle pain, neuropathy, or wound healing challenges, please schedule an appointment with a board-certified podiatrist.
Explore Our Expert Care
Discover the achievements of Foot and Ankle Medical Group, where we have transformed lives through dedicated foot and ankle care. Take a look at some key statistics:
20+
Years of Expertise
200,000+
Successful Treatments
14,000+
Active Patients
5+
Dedicated Specialists
Begin Your Journey to Foot Health at Foot and Ankle Medical Group
At Foot and Ankle Medical Group, we prioritize your health above all. Schedule an appointment today and receive top-tier care from our team of skilled physicians. Committed to excellence, we employ advanced treatments and cutting-edge technology to enhance your foot and ankle health.